Curi RMB Capital LLC Sells 204,089 Shares of Keurig Dr Pepper, Inc $KDP

Key Points

• Curi RMB Capital LLC has reduced its holdings in Keurig Dr Pepper, Inc. by 38.5%, selling 204,089 shares and holding a total of 325,577 shares post-sale, valued at approximately $11.2 million.
• Recent insider trading included Director Robert James Gamgort selling 208,000 shares for about $6.84 million, reducing his ownership by 8.32%.
• Despite recent sell-offs, analysts generally hold a positive outlook on Keurig Dr Pepper, with a consensus rating of "Moderate Buy" and a price target averaging $38.38.

Curi RMB Capital LLC reduced its position in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 38.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 325,577 shares of the company's stock after selling 204,089 shares during the period. Curi RMB Capital LLC's holdings in Keurig Dr Pepper were worth $11,200,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the stock. ST Germain D J Co. Inc. acquired a new stake in Keurig Dr Pepper during the 1st quarter valued at approximately $27,000. WPG Advisers LLC acquired a new stake in Keurig Dr Pepper during the 1st quarter valued at approximately $43,000. Continuum Advisory LLC increased its position in Keurig Dr Pepper by 82.5% during the 1st quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock valued at $46,000 after purchasing an additional 602 shares during the period. Global Trust Asset Management LLC acquired a new stake in Keurig Dr Pepper during the 1st quarter valued at approximately $48,000. Finally, LRI Investments LLC increased its position in Keurig Dr Pepper by 65.6% during the 4th quarter. LRI Investments LLC now owns 1,527 shares of the company's stock valued at $49,000 after purchasing an additional 605 shares during the period. 93.99% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Robert James Gamgort sold 208,000 shares of the stock in a transaction on Friday, August 1st. The stock was sold at an average price of $32.90, for a total value of $6,843,200.00. Following the transaction, the director directly owned 2,292,169 shares in the company, valued at $75,412,360.10. This trade represents a 8.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the transaction, the insider owned 82,511 shares in the company, valued at approximately $2,777,320.26. This represents a 12.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 459,601 shares of company stock worth $15,228,872. 0.40% of the stock is owned by company insiders.

Keurig Dr Pepper Stock Performance

Shares of KDP stock opened at $29.25 on Friday. The company has a market cap of $39.73 billion, a price-to-earnings ratio of 26.12, a price-to-earnings-growth ratio of 1.59 and a beta of 0.47. Keurig Dr Pepper, Inc has a 52 week low of $28.58 and a 52 week high of $38.28. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56. The firm has a 50 day moving average of $33.03 and a 200-day moving average of $33.51.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its earnings results on Thursday, July 24th. The company reported $0.49 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The company had revenue of $4.16 billion for the quarter, compared to analysts' expectations of $4.14 billion. During the same period last year, the business earned $0.45 EPS. Keurig Dr Pepper's quarterly revenue was up 6.1% compared to the same quarter last year. On average, equities analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on KDP shares. Hsbc Global Res downgraded shares of Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 26th. UBS Group decreased their target price on shares of Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a research report on Wednesday, August 27th. Jefferies Financial Group set a $41.00 target price on shares of Keurig Dr Pepper in a research report on Monday, August 25th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating for the company in a research report on Tuesday, August 26th. Finally, Barclays raised their price objective on shares of Keurig Dr Pepper from $37.00 to $39.00 and gave the stock an "overweight" rating in a research report on Monday, July 28th. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $38.38.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.